甲状腺髓样癌的外科治疗进展

Progression of surgical treatment for medullary thyroid cancer

关键词:  甲状腺肿瘤  髓样癌  手术  进展

Key words:  [Key words]　thyroid neoplasm  medullary carcinoma  surgery treatment  progression

摘要:

[摘要]　甲状腺髓样癌(medullary thyroid carcinoma, MTC)为相对少见的恶性肿瘤之一，约占所有甲状腺癌的3%~5%，其组织来源为甲状腺滤泡旁细胞。MTC细胞能够产生降钙素(calcitonin)和其他具有内分泌活性的物质，其临床表现可有腹泻、潮红等类癌综合征或内分泌失调的表现，治疗上主张甲状腺全切除术，故不同于其他类型甲状腺癌。本文就MTC的外科治疗进展作一综述。

Abstract:

[Abstract]　Medullary thyroid cancer (MTC) derives from thyroid parafollicular cells in histology and is a relatively uncommon malignant tumor, accounting for 3%~5% of all thyroid carcinomas. MTC cells can produce calcitonin and other endocrine active substances. The clinical manifestations may have diarrhea, flushing and other carcinoid syndrome or endocrine disorders. Total thyroidectomy is recommended for treatment. So its clinical symptoms and treatments are different from other types of thyroid carcinoma. This article will review the progression in surgical treatment of MTC.